Last updated on January 2018

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder (MDD)


Brief description of study

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder (MDD)

Detailed Study Description

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

Clinical Study Identifier: TX140911

Contact Investigators or Research Sites near you

Start Over

Colleen Figueroa

University of South Florida-Morsani College of Medicine
Tampa, FL USA
  Connect »